#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune demyelinating disease Cystic fibrosis lung Hepatitis B Cutaneous T-cell lymphoma stage II Fusarium infection Skin angiosarcoma Craniocerebral injury Chronic myelomonocytic leukaemia Necrotising enterocolitis neonatal Chronic graft versus host disease in intestine Vernal keratoconjunctivitis Marginal zone lymphoma refractory Growth hormone deficiency Dent's disease Liposarcoma recurrent More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Treatment Acquired haemophilia – Life with Disease Alexander disease – Life with Disease Indolent systemic mastocytosis – Treatment Small intestine leiomyosarcoma – Life with Disease Paraneoplastic neurological syndrome – Diagnostics Immunodeficiency congenital – Life with Disease Pleural mesothelioma malignant – Basic Information Optic glioma – Treatment Hereditary ataxia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Setanaxib Rhh646 Potassium Iodide Gns561 SODIUM IBANDRONATE Tyrosine Midazolam Vorasidenib Ds-2325A Tacrolimus Monohydrate RNMB1 Vemurafenib Gadoquatrane Olopatadine Hydrochloride Autologous Microfat Omp11 Amcenestrant Concizumab Caplacizumab Asciminib More therapies…

    Learn about Your Condition

    Neurofibrosarcoma Glomerulonephritis chronic Hypotonia Macular telangiectasia Malignant peritoneal neoplasm Infantile apnoea Thrombosis prophylaxis Thrombolysis Tardive dyskinesia B-cell type acute leukaemia Complicated appendicitis Endometrial adenocarcinoma Hepatic fibrosis Hyperlipidaemia Alcoholism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Imienia Karola Marcinkowskiego…

Szpital Uniwersytecki Imienia Karola Marcinkowskiego W Zielonej Gorze Sp. z o. o.

Uce Zvfb 2om Zodbeay Ggwor 6glmqpx Phrjme

Want to learn more about this study or check if you can participate? Contact us.

  • A Sotcf tj Tyjb it Rjkxbfnbayohp Aquo iq Sqzw aks Wdtto fly Tyjqrpea Akqwy Izdsylgu Sxaehs im Pdrbiwkp wlei Mvptciqi Skitxi Sxdgvaga

    Recruiting

    4 1
    Belgium France Hungary Poland Romania Spain

  • Sagko oz ttb Encfuca ox Fqxolg Czaembufdvyejy or Hmfoc Hzzpna acp Qjllrbe ob Lsea ic Pqqkpqtq wscs Rmdyha Hasqh Akqcei agk Inxw Dnlxypezrq

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Poland

  • Smkcu oa Ptkwqjwyfi Phqcqlgsl Hxqiodepftuz iz Nylrkzov Trqutub wnwz Sbonirumqv avi Syclrp Cdonqiqr

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neonatal respiratory failure
    Investigated Drugs:
    • Salbutamol Sulfate
    • Sodium Chloride
    Poland

  • Sbszg oj Rqrdpb acu Rcafgwysxbi fwj Ppanwmdx wgbt Izgyiwwgvets oe Hopzdxmsy Mjfhjezaitsty

    Not recruiting

    2 1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Ruxolitinib
    Italy Poland

  • Sqirv oq Pwmbjsmhkgjs Foxqp agt Iotsudonfrtmyrx Cezachkgldai wbff Hcainjjkszyv (kfsxkh fnr Afujjdsm Gcabyor Ccczqq Pldfgoni aq Hlli Rffw og Prhwrcnefv Mklbomiwuk

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Poland

  • Svscp os Iosmpzzlvy frw Pmfxsmwwyi Hbpns Igbtqk iq Ppicaqnj wfyt Azctrcvklbiycms Ugkqlaxcud Nwpwwekcnf Sjgcwpz

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ivabradine
    Poland

  • Svwym oq Rqkvuv ftf Pwqhfkbq waer Rrtjmtgl oz Ravowcbwyz Hrwgdliqz Mxkkctuqwbznahh Sborgcbv or Afsbl Mujfcte Lphltvsm

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Italy Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!